Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

BioPorto - Presentation of strategic plans

By HC Andersen Capital
BioPorto

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Meet and ask questions to interim CEO Peter Mørch Eriksen from BioPorto on 22 February at 2.00 PM.

BioPorto - an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI) - will publish its strategic plans.

Disclaimer: HC Andersen Capital receives payment from Bioporto for a DigitalIR/Corporate Visibility and IR advisory agreement./Claus Thestrup 20 February 08.57 AM.

Recent videos

Scanfil press conference
23.01.2026, 13.00 Scanfil
AKTIER MED FRIIS - UGE 4 2026
23.01.2026, 12.00
HCA Morgenbørs 23/01 - Udsigt til flad stemning i Europa med fokus på Novo Nordisk og Bavarian
23.01.2026, 09.17 Pandora
HCA Morgenbørs 21/01 - Positivt futures-marked og fokus på møderne i Davos og kursmål
21.01.2026, 09.25 Genmab
Admicom, Webcast, Q4'25
21.01.2026, 09.00 Admicom
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.